Patent applications published 10 March 2010
Hwail Pharmaceutical; Yu, Hyo Gyoung 2160180*
- Nano-emulsion compsn of coenzyme Q10
Hwail Pharmaceutical; Yu, Hyo Gyoung 2160180*
- Formulations and methods for treating dry eye
Aciex Therapeutics 2160182*
- Extended release formulations comprising quetipine and methods for their manufacture
AstraZeneca 2160183*
- Hypercompressed particles for controlled release of ophthalmic medications
Sustained Nano Systems 2160184*
- Methods of making and using nanoparticles
Nanosolutions 2160185*
- Creatine compsns for skin treatment
Avicena 2160186*
- Spiroindalones
Merck Sharp & Dohme 2160187*
- Prokinetic agent for bowel preparation
Theravance 2160188*
- 5-beta, 14-beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
Sigma-Tau Industrie Farmaceutiche Riunite 2160190*
- Suppression of viruses involved in respiratory infection or disease
Johnson & Johnson Research 2160191*
- Antimicrobial materials and coatings
Tyco Healthcare 2160192*
- Furanone copolymers
Tyco Healthcare 2160193*
- Novel muscle relaxant using negative charge gold nanoparticle with choline
Chin, Chur 2160195*
- Compounds for the treatment of ischaemia and neurodegeneration
Oncoreg 2160196*
- Adenoviral vector encoding malaria antigen
ISIS Innovation 2160197*
- Influenza vaccines
Statens Serum Institut 2160198*
- Class A oligonucleotides with immunostimulatory potency
Coley Pharmaceutical Group, Inc; Coley Pharmaceutical GmbH 2160199*
- Antibody-light fusion products for cancer therapeutics
University of Chicago 2160200*
- Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin
Cyto Pulse Sciences 2160201*
- Compounds emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
nanoPET Pharma 2160202*
- Novel crystalline forms of atovaquone
Hetero Drugs 2160376*
- Targeting diazo prodrugs for the treatment of gastrointestinal diseases
The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin 2160377*
- Method for synthesising an N-unsubstituted or N-substituted aziridine
BASF 2160379*
- Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
Probiodrug 2160380*
- Spirocyclic quinazoline derivatives and their use as PDE7 inhibitors
Pfizer 2160381*
- Preparation of nanoscalar UV absorbers
BASF 2160382*
- Process for the preparation of valsartan
Quimica Sintética 2160384*
- 2-substituted isoflavonoid compounds, medicaments and uses
Novogen Research 2160385*
- Therapeutic ((phenyl)imidazolyl)methyl-quinolinyl compounds
Allergan 2160386*
- Heteroarylamide pyrimidine compounds
Sanofi-Aventis; Mitsubishi Tanabe Pharma 2160387*
- Arylamide pyrimidone compounds
Sanofi-Aventis; Mitsubishi Tanabe Pharma 2160388*
- Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
Probiodrug 2160389*
- Novel process
Generics [UK] 2160390*
- Nicotinamide derivatives as synthesis units for producing agrochemical substances, and method for the production thereof
Bayer CropScience 2160391*
- Novel macrocyclic inhibitors of hepatitis C virus replication
Intermune; Array Biopharma 2160392*
- Novel compounds as cannabinoid receptor ligands
Abbott Laboratories 2160393*
- Tenofovir disoproxil hemi-fumaric acid co-crystal
Ultimorphix Technologies 2160394*
- Stevioside polymorphic and amorphous forms, methods for their formulation and uses
The Coca-Cola Company 2160395*
- Thiocarbon-protecting groups for RNA synthesis
Agilent Technologies 2160396*
- A novel and highly stereoselective process for preparing gemcitabine and intermediates thereof
Nanjing Cavendish Bio-Engineering Technology; Xu, Yongxiang 2160397*
- Industrial method for the synthesis of 17-acetoxy-11B-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
Richter Gideon Nyrt 2160398*
- Novel methods for recovery of leaf proteins
University of Maryland 2160399*
- Peptides as antimicrobial agents towards campylobacter SPP
Australian Poultry CRC Pty 2160400*
- Fusion molecules and IL-15 variants
Altor BioScience 2160401*
- Signalling peptides
Transgene 2160402*
- Methods of producing a secreted protein
Genzyme; Biochemical Institute 2160403*
- Azapeptides as CD36 binding compounds
Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; INSERM (Institut National de la Santé et de la Recherche Medicale) 2160404*
- Expression of soluble antibody fragment by truncation of CH1 domain
Dow Global Technologies 2160405*
- Antibodies useful for therapy and diagnosis of cancer
Avir Green Hills Biotechnology Research Development Trade 2160406*
- Neutralising antibodies
CRC for Asthma and Airways 2160407*
- Use of antibodies against the CD52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and Alzheimer’s disease
Bayer Schering Pharma 2160408*
- Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
Ablynx 2160409*
- Induction of tolerogenic phenotype in mature dendritic cells
Novartis; Fondazione Centro San Raffaele del Monte Tabor 2160410*
- Anti-VPAC1 antibodies and their uses
ThromboGenics; Life Science Research Partners 2160411*
- Humanised and chimeric anti-CD59 antibodies that mediate cancer cell cytotoxicity
F Hoffmann-La Roche 2160412*
- Method of preparing alkali cellulose or a cellulose derivative
Dow Global Technologies 2160413*
- Hyperactive variants of the transposase protein of the transposon system Sleeping Beauty
Mex-Delbrück-Centrum für Molekulare Medizin 2160461*
- Novel constructs for expression of influenza virus
Avir Green Hills Biotechnology Research Development Trade 2160462*
- A method for the construction of cancer-specific promoters using functional genomics
Regulon 2160463*
- Nucleic acid functionalised nanoparticles for therapeutic applications
Northwestern University 2160464*
- Tumour growth inhibitory compounds and method of their use
Index Pharmaceuticals 2160465*
- Treatment and prevention of influenza
MAT Malta Advanced Technologies; The Commonwealth Scientific and Industrial Research Organisation 2160466*
- Methods and means for exact replacement of target DNA in eukaryotic organisms
Bayer BioScience; Bayer CropScience 2160467*
- Screening tool for antiviral agents
Saint Louis University 2160468*
- Method for producing a recombinant protein on a manufacturing scale
Boehringer Ingelheim RCV 2160469*
- Chimeric PUFA polyketide synthase systems and uses thereof
Martek Biosciences 2160470*
- Method of identifying compounds that modulate regulation of iron response elements
Toucan Capital Corp 2160473*
- Nucleotide analogues
Helicos Biosciences 2160474*
- Markers and methods for assessing and treating Crohn’s disease and related disorders
Centocor Ortho Biotech 2160475*
- Micro-RNA scaffolds and non-naturally occurring micro-RNAs
Dharmacon 2160477*
- Predictive diagnosis for kidney disease
Siemens Healthcare Diagnostics 2160478*
- Methods and systems for applying therapeutic agent to a medical device
Boston Scientific Scimed 2160483*